• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素-蛋白酶体系统在亨廷顿病中的作用。

Ubiquitin-proteasome system involvement in Huntington's disease.

机构信息

Department of Molecular Biology, Centro de Biología Molecular "Severo Ochoa," Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid (UAM), Centro Investigación Biomédica en Red Enfermedades Neurodegenerativa (CIBERNED), Madrid, Spain.

出版信息

Front Mol Neurosci. 2014 Sep 29;7:77. doi: 10.3389/fnmol.2014.00077. eCollection 2014.

DOI:10.3389/fnmol.2014.00077
PMID:25324717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4179678/
Abstract

Huntington's disease (HD) is a genetic autosomal dominant neurodegenerative disease caused by the expansion of a CAG repeat in the huntingtin (htt) gene. This triplet expansion encodes a polyglutamine stretch (polyQ) in the N-terminus of the high molecular weight (348-kDa) and ubiquitously expressed protein htt. Normal individuals have between 6 and 35 CAG triplets, while expansions longer than 40 repeats lead to HD. The onset and severity of the disease depend on the length of the polyQ tract: the longer the polyglutamine stretch (polyQ) is, the earlier the disease begins and the more severe the symptoms are. One of the main histopathological hallmarks of HD is the presence of intraneuronal proteinaceous inclusion bodies, whose prominent and invariant feature is the presence of ubiquitin (Ub); therefore, they can be detected with anti-ubiquitin and anti-proteasome antibodies. This, together with the observation that mutations in components of the ubiquitin-proteasome system (UPS) give rise to some neurodegenerative diseases, suggests that UPS impairment may be causative of HD. Even though the link between disrupted Ub homeostasis and protein aggregation to HD is undisputed, the functional significance of these correlations and their mechanistic implications remains unresolved. Moreover, there is no consistent evidence documenting an accompanying decrease in levels of free Ub or disruption of Ub pool dynamics in neurodegenerative disease or models thus suggesting that the Ub-conjugate accumulation may be benign and just underlie lesion in 26S function. In this chapter we will elaborate on the different studies that have been performed using different experimental approaches, in order to shed light to this matter.

摘要

亨廷顿病(HD)是一种由亨廷顿(htt)基因中 CAG 重复扩展引起的常染色体显性遗传神经退行性疾病。这种三核苷酸扩展在高分子量(348kDa)和广泛表达的 htt 蛋白的 N 端编码一段聚谷氨酰胺延伸(polyQ)。正常个体有 6 到 35 个 CAG 三核苷酸,而超过 40 个重复的扩展会导致 HD。疾病的发病和严重程度取决于 polyQ 片段的长度:polyQ 延伸越长,疾病开始得越早,症状越严重。HD 的主要组织病理学特征之一是存在神经元内蛋白包涵体,其突出和不变的特征是存在泛素(Ub);因此,可以用抗泛素和抗蛋白酶体抗体检测到它们。这一点,再加上观察到泛素-蛋白酶体系统(UPS)成分的突变会导致一些神经退行性疾病,表明 UPS 损伤可能是 HD 的原因。尽管 Ub 动态平衡破坏和蛋白质聚集与 HD 之间的联系是无可争议的,但这些相关性的功能意义及其机制意义仍未解决。此外,没有一致的证据证明在神经退行性疾病或模型中存在游离 Ub 水平降低或 Ub 池动力学紊乱,这表明 Ub 缀合物的积累可能是良性的,只是 26S 功能的病变基础。在本章中,我们将详细阐述使用不同实验方法进行的不同研究,以阐明这一问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01c/4179678/1bea9536fb33/fnmol-07-00077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01c/4179678/b879ca5af8e0/fnmol-07-00077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01c/4179678/1bea9536fb33/fnmol-07-00077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01c/4179678/b879ca5af8e0/fnmol-07-00077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01c/4179678/1bea9536fb33/fnmol-07-00077-g002.jpg

相似文献

1
Ubiquitin-proteasome system involvement in Huntington's disease.泛素-蛋白酶体系统在亨廷顿病中的作用。
Front Mol Neurosci. 2014 Sep 29;7:77. doi: 10.3389/fnmol.2014.00077. eCollection 2014.
2
Ubiquitin-modifying enzymes in Huntington's disease.亨廷顿病中的泛素修饰酶
Front Mol Biosci. 2023 Feb 8;10:1107323. doi: 10.3389/fmolb.2023.1107323. eCollection 2023.
3
Global changes to the ubiquitin system in Huntington's disease.亨廷顿舞蹈病中泛素系统的整体变化
Nature. 2007 Aug 9;448(7154):704-8. doi: 10.1038/nature06022.
4
Huntington’s Disease Pathogenesis: Mechanisms and Pathways亨廷顿舞蹈症发病机制:机制与途径
5
Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.亨廷顿蛋白丝可抑制26S蛋白酶体活性,但从小鼠和人类大脑中分离出的包涵体则无此作用。
J Neurochem. 2006 Sep;98(5):1585-96. doi: 10.1111/j.1471-4159.2006.03968.x. Epub 2006 Jun 19.
6
Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.神经元与神经胶质细胞中泛素-蛋白酶体系统的不同活性可能是错误折叠蛋白在神经元中优先积累的原因。
J Neurosci. 2008 Dec 3;28(49):13285-95. doi: 10.1523/JNEUROSCI.4393-08.2008.
7
The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.亨廷顿舞蹈症细胞模型中早期转录变化和聚集体形成的动力学
BMC Genomics. 2017 May 12;18(1):373. doi: 10.1186/s12864-017-3745-z.
8
Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.青少年亨廷顿舞蹈病皮肤成纤维细胞对 Parkin 水平升高和蛋白酶体活性增加做出反应,作为抵消突变亨廷顿蛋白病理后果的潜在机制。
Int J Mol Sci. 2019 Oct 26;20(21):5338. doi: 10.3390/ijms20215338.
9
The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.泛素连接酶 Ube2W 调节亨廷顿病蛋白 huntingtin 的可溶性。
Neurobiol Dis. 2018 Jan;109(Pt A):127-136. doi: 10.1016/j.nbd.2017.10.002. Epub 2017 Oct 3.
10
The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity.泛素受体 ADRM1 调节 HAP40 诱导的蛋白酶体活性。
Mol Neurobiol. 2017 Nov;54(9):7382-7400. doi: 10.1007/s12035-016-0247-y. Epub 2016 Nov 5.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Mitochondria and Endoplasmic Reticulum Contact Site as a Regulator of Proteostatic Stress Responses in Neurodegenerative Diseases.线粒体与内质网接触位点作为神经退行性疾病中蛋白质稳态应激反应的调节因子
Bioessays. 2025 May 4:e70016. doi: 10.1002/bies.70016.
3
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.

本文引用的文献

1
Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.活性蛋白酶体动态募集到多聚谷氨酰胺引发的包涵体中。
FEBS Lett. 2014 Jan 3;588(1):151-9. doi: 10.1016/j.febslet.2013.11.023. Epub 2013 Nov 26.
2
Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes.含有扩展多聚谷氨酰胺的 N 端 huntingtin 片段完全被哺乳动物蛋白酶体降解。
J Biol Chem. 2013 Sep 20;288(38):27068-27084. doi: 10.1074/jbc.M113.486076. Epub 2013 Aug 1.
3
Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.
不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
4
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.针对亨廷顿病的衰老和细胞衰老的治疗方法。
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
5
Huntingtin contains an ubiquitin-binding domain and regulates lysosomal targeting of mitochondrial and RNA-binding proteins.亨廷顿蛋白包含一个泛素结合结构域,调节线粒体和 RNA 结合蛋白的溶酶体靶向。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2319091121. doi: 10.1073/pnas.2319091121. Epub 2024 Jul 29.
6
Gastrodin Improves the Activity of the Ubiquitin-Proteasome System and the Autophagy-Lysosome Pathway to Degrade Mutant Huntingtin.天麻素通过改善泛素-蛋白酶体系统和自噬溶酶体通路活性来降解突变型亨廷顿蛋白。
Int J Mol Sci. 2024 Jul 14;25(14):7709. doi: 10.3390/ijms25147709.
7
TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease.TRIM37 是灵长类动物特有的亨廷顿蛋白 E3 连接酶,负责亨廷顿病的纹状体变性。
Sci Adv. 2024 May 17;10(20):eadl2036. doi: 10.1126/sciadv.adl2036.
8
HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.HAP40 调节亨廷顿病小鼠中突变型亨廷顿蛋白的聚集和毒性。
Cell Death Dis. 2024 May 14;15(5):337. doi: 10.1038/s41419-024-06716-4.
9
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders.二甲双胍:从理解其分子机制到证明其在神经退行性疾病中的治疗益处的曲折历程。
Pharmaceuticals (Basel). 2023 Dec 11;16(12):1714. doi: 10.3390/ph16121714.
10
The ubiquitin thioesterase YOD1 ameliorates mutant Huntingtin induced pathology in Drosophila.泛素硫酯酶 YOD1 可改善果蝇中突变型 Huntingtin 引起的病变。
Sci Rep. 2023 Dec 11;13(1):21951. doi: 10.1038/s41598-023-49241-8.
携带亨廷顿病突变的转基因小鼠中早期包涵体形成过程中聚集和泛素化的时间分离。
PLoS One. 2012;7(7):e41450. doi: 10.1371/journal.pone.0041450. Epub 2012 Jul 24.
4
Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.泛素连接酶 Ube3a 的功能障碍可能与亨廷顿病小鼠模型中的突触病理生理学有关。
J Biol Chem. 2012 Aug 24;287(35):29949-57. doi: 10.1074/jbc.M112.371724. Epub 2012 Jul 11.
5
Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease.亨廷顿病细胞模型中 26S 蛋白酶体活性的间接抑制。
J Cell Biol. 2012 Mar 5;196(5):573-87. doi: 10.1083/jcb.201110093. Epub 2012 Feb 27.
6
Characterization of the Brain 26S Proteasome and its Interacting Proteins.脑 26S 蛋白酶体及其相互作用蛋白的特性。
Front Mol Neurosci. 2010 May 21;3. doi: 10.3389/fnmol.2010.00012. eCollection 2010.
7
Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.抑制泛素-蛋白酶体系统会导致毒性 N 端突变 huntingtin 片段的优先积累。
Hum Mol Genet. 2010 Jun 15;19(12):2445-55. doi: 10.1093/hmg/ddq127. Epub 2010 Mar 30.
8
Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation.急性多聚谷氨酰胺表达在可诱导的小鼠模型中揭示了泛素/蛋白酶体系统损伤和归因于聚集体形成的永久性恢复。
J Neurosci. 2010 Mar 10;30(10):3675-88. doi: 10.1523/JNEUROSCI.5673-09.2010.
9
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.IKK 使 Huntingtin 磷酸化,并使其通过蛋白酶体和溶酶体进行降解。
J Cell Biol. 2009 Dec 28;187(7):1083-99. doi: 10.1083/jcb.200909067. Epub 2009 Dec 21.
10
Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.模拟蛋白酶体释放多聚谷氨酰胺肽会引发聚集和毒性。
J Cell Sci. 2009 Sep 15;122(Pt 18):3262-71. doi: 10.1242/jcs.045567. Epub 2009 Aug 18.